This study was designed to assess the safety of retrieval of the Bard Recovery® G2® Filter System. The G2 filter is an FDA-cleared device for inferior vena caval interruption in patients with pulmonary thromboembolism.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
100
Retrieval of previously placed RECOVERY G2 IVC filter
Technical Success (Retrieval)
Technical success for retrieval of the filter such that the entire filter is removed.
Time frame: 1 month post filter retrieval or through 6 months following implantation
Clinical Success (Retrieval)
technical success without subsequent damage to the cava wall or other retrieval-related complications requiring intervention.
Time frame: Time of Retrieval or through 6 months of implantation
Percentage of Participants With Adverse Events Through 30 Days Post Retrieval
Adverse events occurring at the time of retrieval through 30 days post filter retrieval procedure
Time frame: 30 days post retrieval
Filter Migration > 2cm
Percentage of subjects experiencing filter migrations from the initial placement position of 2cm or more.
Time frame: 30 days post retrieval or 6 months following filter placement
Incidence of Filter Fracture
occurrence of fracture assessed at retrieval by the Investigator (broken filter arms, legs, or other components)
Time frame: at 6 months or at retrieval of the filter
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.